First Time Loading...

Magellan Health Inc
NASDAQ:MGLN

Watchlist Manager
Magellan Health Inc Logo
Magellan Health Inc
NASDAQ:MGLN
Watchlist
Price: 94.99 USD Market Closed
Updated: Jun 1, 2024

Net Margin
Magellan Health Inc

6.3%
Current
3.2%
Average
2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.3%
=
Net Income
302m
/
Revenue
4.8B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
US
Magellan Health Inc
NASDAQ:MGLN
2.5B USD
6%
US
UnitedHealth Group Inc
NYSE:UNH
456.7B USD
4%
US
Elevance Health Inc
NYSE:ELV
125.2B USD
4%
US
Anthem Inc
NYSE:ANTM
116.4B USD
4%
US
Humana Inc
NYSE:HUM
43.2B USD
2%
US
Centene Corp
NYSE:CNC
38.4B USD
2%
US
Molina Healthcare Inc
NYSE:MOH
18.6B USD
3%
US
Healthequity Inc
NASDAQ:HQY
7B USD
6%
BR
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
6.4B USD
7%
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
29.9B BRL
-2%
US
Progyny Inc
NASDAQ:PGNY
2.6B USD
6%
Magellan Health Inc
NASDAQ:MGLN
Country US
Market Cap 2.5B USD
Net Margin
6%
UnitedHealth Group Inc
NYSE:UNH
Country US
Market Cap 456.7B USD
Net Margin
4%
Elevance Health Inc
NYSE:ELV
Country US
Market Cap 125.2B USD
Net Margin
4%
Anthem Inc
NYSE:ANTM
Country US
Market Cap 116.4B USD
Net Margin
4%
Humana Inc
NYSE:HUM
Country US
Market Cap 43.2B USD
Net Margin
2%
Centene Corp
NYSE:CNC
Country US
Market Cap 38.4B USD
Net Margin
2%
Molina Healthcare Inc
NYSE:MOH
Country US
Market Cap 18.6B USD
Net Margin
3%
Healthequity Inc
NASDAQ:HQY
Country US
Market Cap 7B USD
Net Margin
6%
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
Country BR
Market Cap 6.4B USD
Net Margin
7%
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Country BR
Market Cap 29.9B BRL
Net Margin
-2%
Progyny Inc
NASDAQ:PGNY
Country US
Market Cap 2.6B USD
Net Margin
6%

Profitability Report

View the profitability report to see the full profitability analysis for Magellan Health Inc.

Full Profitability Report

See Also

Summary
MGLN intrinsic value, competitors valuation, and company profile.
DCF Valuation
MGLN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MGLN stock valuation using valuation multiples.
Wall Street Estimates
MGLN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MGLN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
6.3%
=
Net Income
302m
/
Revenue
4.8B
What is the Net Margin of Magellan Health Inc?

Based on Magellan Health Inc's most recent financial statements, the company has Net Margin of 6.3%.

ALPHA SPREAD
Join more than 142,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.